|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| C07K 16/32 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 4403228 |
| (13) | Kind of document | T |
| (96) | European patent application number | 24174637.9 |
| Date of filing the European patent application | 2012-10-11 | |
| (97) | Date of publication of the European application | 2024-07-24 |
| (45) | Date of publication and mention of the grant of the patent | 2025-07-16 |
| (46) | Date of publication of the claims translation | 2025-10-27 |
| (30) | Number | Date | Country code |
| 201161547535 P | 2011-10-14 | US | |
| 201161567015 P | 2011-12-05 | US | |
| 201261657669 P | 2012-06-08 | US | |
| 201261682037 P | 2012-08-10 | US | |
| 201261694584 P | 2012-08-29 | US |
| (72) |
ALAVATTAM, Sreedhara , US
ALMER, Lukas C. , US
BENYUNES, Mark C. , US
DE TOLEDO PELIZON, Christina H , CH
KWONG GLOVER, Zephania W. , US
MITCHELL, Lada , CH
RATNAYAKE, Jayantha , GB
ROSS, Graham A. , GB
WALKER, Ru-Amir , US
CLARK, Emma I. , GB
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | HER2 dimerizacijos inhibitoriaus pertuzumabo panaudojimo būdai ir gamybos produktas, į kurio sudėtį jis įeina |
| USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INHIBITOR PERTUZUMAB |
| Payment date | Validity (years) | Amount | |
| 2025-09-23 | 14 | 289.00 EUR |
| 2026-10-11 |